Get started
Author

Antonia Helen Westenberg

Observed names: A H Helen Westenberg, A H Westenberg, A Helen Westenberg, A. H. Westenberg, A. Helen Westenberg, A.H. Westenberg, Antonia H. Westenberg, Westenberg, A. H., Westenberg, A. Helen, Westenberg, A.H.
ORCID: 0000-0002-1466-2676
Observed ORCID: 0000-0002-1466-2676
OpenAlex ID: A5041591189
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
2014 · Mila Donker, Geertjan van Tienhoven, et al. · The Lancet Oncology · 1,871
Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)
2017 · L. M. van Roozendaal, M. L. G. Vane, et al. · BMC Cancer · 188
PDF
Inflammatory breast cancer: An overview
2014 · D.J.P. van Uden, H.W.M. van Laarhoven, et al. · Critical Reviews in Oncology/Hematology · 137
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study
2022 · Boon H Chua, Emma K Link, et al. · The Lancet · 108
PDF
The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)
2015 · L. M. van Roozendaal, J. HW de Wilt, et al. · BMC Cancer · 81
PDF
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3‐98
2013 · Elżbieta Senkus, Henry Gomez, et al. · Psycho-Oncology · 76
Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial
2018 · Patricia J.A.M. Brouwers, Erik van Werkhoven, et al. · Radiotherapy and Oncology · 75
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial
2020 · Madeleine T King, Emma K Link, et al. · The Lancet Oncology · 51
Patient-reported outcomes in ductal carcinoma in situ: A systematic review
2016 · Madeleine T. King, Zoë E. Winters, et al. · European Journal of Cancer · 48
Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: Identification rate and nodal outcome
2013 · Mila Donker, Marieke E. Straver, et al. · European Journal of Cancer · 48
Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial
2023 · Bruno Meduri, Antonella Baldissera, et al. · Journal of Clinical Oncology · 41
Dutch breast reconstruction guideline
2017 · Marc A.M. Mureau, R.R.W.J. van der Hulst, et al. · Journal of Plastic Reconstructive & Aesthetic Surgery · 37
Value of fluorodeoxyglucose positron emission tomography in women with breast cancer
2005 · M L E A Landheer, M G Steffens, et al. · British journal of surgery · 32
PDF
Circulating tumor DNA detection after neoadjuvant treatment and surgery predicts recurrence in patients with early-stage and locally advanced rectal cancer
2023 · Lisa S.M. Hofste, Maartje J. Geerlings, et al. · European Journal of Surgical Oncology · 28
PDF
Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial
2016 · Patricia J.A.M. Brouwers, Erik van Werkhoven, et al. · Radiotherapy and Oncology · 21
Post-irradiation angiosarcoma of the greater omentum.
1989 · A H Westenberg, T Wiggers, et al. · PubMed · 19
Radiotherapy for Ledderhose disease: Results of the LedRad-study, a prospective multicentre randomised double-blind phase 3 trial
2023 · Anneke de Haan, Johanna G.H. van Nes, et al. · Radiotherapy and Oncology · 17
PDF
De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1–2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07)
2024 · Sabine R de Wild, Lori M van Roozendaal, et al. · British journal of surgery · 16
PDF
Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial
2023 · V.M. Wintraecken, L.J. Boersma, et al. · Radiotherapy and Oncology · 16
PDF
International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast
2019 · Ivo A. Olivotto, Emma Link, et al. · Radiotherapy and Oncology · 12
Abstract GS2-04: A randomized phase III study of radiation doses and fractionation schedules in non-low risk ductal carcinoma in situ (DCIS) of the breast (BIG 3-07/TROG 07.01)
2021 · Boon Hui Chua, Emma Link, et al. · Cancer Research · 9
Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial
2026 · Laura R Moolenaar, Mahsoem Ali, et al. · ˜The œLancet. Gastroenterology & hepatology · 6
Axillary Lymph Node Dissection vs Axillary Radiotherapy: A Detailed Analysis of Morbidity
2014 · Mila Donker, E. Rutgers, et al. · Data Archiving and Networked Services (DANS) · 4
Universal Transcutaneous Bilirubin Screening in a Midwifery-Led Home Care Setting
2026 · Lauren E. H. Westenberg, Marten J. Poley, et al. · JAMA Network Open · 2
An economic evaluation of radiotherapy for patients with symptomatic Ledderhose disease
2023 · Anneke de Haan, Henk Groen, et al. · Radiotherapy and Oncology · 2
PDF
Works count: 39
Citation count: 2,952
H-index: 17
I10-index: 20
Year
Topic
Type